期刊文献+

不同维持剂量咖啡因治疗早产儿呼吸暂停的疗效观察 被引量:4

Different Maintenance Dose plus Caffeine Curative Effect Observation of Treatment of Premature Infant Apnea
下载PDF
导出
摘要 目的探讨不同维持剂量咖啡因治疗早产儿呼吸暂停的疗效。方法将我院NICU 2012年1月至2014年11月3年间收治并符合条件的77例出现呼吸暂停的早产儿随机分为3组,A组23例,B组28例,C组26例,三组均在常规治疗(按摩脊背,弹足底,俯卧位,若不能缓解并出现发绀时予以复苏囊正压给氧)的基础上,使用咖啡因治疗,先给予20mg/kg负荷量,24h后三组分别给予5mg/kg、10mg/kg、15mg/kg维持。结果 B、C两组发生呼吸暂停的次数明显减少,治疗时间较A组明显缩短,停药时间提前,A、B两组相比,A、C两组相比差异有统计学意义(P<0.05);B、C两组相比差异无统计学意义(P>0.05)。结论早产儿呼吸暂停使用咖啡因治疗先用20mg/kg负荷量后,维持量用10mg/kg效果明显。 Objective To explore the curative effect of different maintenance dose plus caffeine for the treatment of pre- mature infant apnea. Methods From January 2012 - November 2014 treated 80 cases in NICU with apnea of premature infants were randomly divided into 3 groups, group A (23 cases), group B (28 cases), group C (26 cases), three groups were received routine therapy ( massage back, playing A foot, the prone position, if cant ease and Cyanosis when recovery capsule positive pres- sure to oxygen), on the basis of using caffeine treatment, providing first 20 mg,/kg body weight load. 24 hours later the three groups were given 5 mg/kg, 10 mg/kg, and 15 mg/kg. Results The rate of apnea was significantly reduce in group B and C and the treatment time was shortened obviously compared with group A. A, B, compared two groups A and C was statistically significant difference in two groups, P 〈 0. 05 ; B, C, there was no statistically significant difference in two groups(P 〉 0. 05 ). Conclusion The premature infant apnea using caffeine after treatment with 20 mg/kg load first, maintain the quantity with 10 mg/kg body weight.
作者 焦德清
出处 《四川医学》 CAS 2015年第8期1127-1129,共3页 Sichuan Medical Journal
关键词 早产儿 呼吸暂停 咖啡因 维持剂量 premature infants apnea caffeine maintenance dose
  • 相关文献

参考文献11

  • 1Aranda JV, Beharry K, Valencia GB, et al. Caffeine impact on neonatal morhidities[ J ]. J Matem Fetal Neonatal Med ,2010 ,23 :20-23.
  • 2Picone S, Bedetta M, Paolillo P. Caffeine citrate: when and for how long. A literature review[ J ]. J Matem Fetal Neonatal Med, 2012, 25 : 11-14.
  • 3Natarajan G, Botica ML, Aranda JV. Pharmacology Review: Clinical pharmacology of caffeine in the newborn [ J ]. NeoReviews, 2007, 8:214-221.
  • 4袁琳,陈超.咖啡因在新生儿中的临床应用[J].世界临床药物,2009,30(9):518-522. 被引量:25
  • 5Charles BG, Townsend SR, Steer PA, et al. Caffeine citrate treatment for extremely premature infants with apnea: population phannacokinet- ics, absolute bioavallability, and implications for therapeutic drug moni- toring[ J]. Ther Drug Monit,2008,30:709-716.
  • 6Mayer CA, Haxhiu MA, Martin LJ,et al. Adenosine A2A receptors me- diate GABAcrgic inhibition of respiration in immature rats[J]. J Appl Physiol( 1985 ) ,2006,100:91-97.
  • 7Wilson CG,Martin RJ,Jaber M,et al. Adenosine A2A receptors inter- act with GABAergic pathways to modulate respiration in neonatal pig- lets [ J ]. Respir Physiol Ncurobiol,2004,141,201-211.
  • 8Kumral A, Tuzun F, Yesilirmak DC, et al. Genetic basis of apnoea of prematurity and caffeine treatment response:role of adenosine receptor polymorphisms:genetic basis of apnoea of prematurity[ J ]. Acta Paedi- atr,2012,101 : e299-303.
  • 9Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity [ J ]. N Engl J Med, 2007, 357 : 1893-1902.
  • 10Patel RM, Leong T, Carlton DP,et al. Early caffeine therapy and clini- cal outcomes in extremely preterm infants [J]. J Pcrinatol, 2013, 33 : 134-140.

二级参考文献2

  • 1A. C. Falc?o,M. M. Fernández de Gatta,M. F. Delgado Iribarnegaray,D. Santos Buelga,M. J. García,A. Dominguez-Gil,J. M. Lanao. Population pharmacokinetics of caffeine in premature neonates[J] 1997,European Journal of Clinical Pharmacology(3):211~217
  • 2苏兴文,皮荣标,林穗珍,邱鹏新,唐孝礼,万翔,黎明涛,颜光美.咖啡因对谷氨酸诱导神经元凋亡的保护作用[J].中国药理学通报,1999,15(6):509-512. 被引量:11

共引文献24

同被引文献43

  • 1陈超,魏克伦,姚裕家,陈大庆.早产儿管理指南[J].中华儿科杂志,2006,44(3):188-191. 被引量:324
  • 2邵肖梅,叶鸿瑁,丘小汕.实用新生儿学.第4版.北京:人民卫生出版社,2011.
  • 3Comer AM, Perry CM, Figgitt DP. Caffeine citrate: a review of its use in apnoea of prematurity. Paediatric Drugs, 2001, 3(1):61-79.
  • 4Kreutzer K, Bassler D. Caffeine for apnea of prematurity: a neonatal success story. Neonatology, 2014, 105(4):332-336.
  • 5Skouroliakou M, Baeopoulou F, Markantonis SL. Caffeine versus theoph~lline for apnea of prematurity: a randomised controlled trial. J Paediatr Child Health, 2009, 45(10):587-592.
  • 6Mohammed S, Nour I, Shabaan AE, et al. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial. Eur J Pediatr, 2015, 174(7):949-956.
  • 7Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2013 update. Neonato|ogy, 2013, 103(4):353-368.
  • 8龙飞舞,唐政华,刘涛.经鼻持续气道正压通气联合肺泡表面活性物质治疗早产儿呼吸窘迫综合征[J].医学临床研究,2011,28(5):879-881. 被引量:2
  • 9赵婧,母得志.早产儿呼吸暂停诊治进展[J].临床儿科杂志,2012,30(3):291-294. 被引量:58
  • 10张馨丹,王晓鹏,田秀英,郑军,高琦.INSURE技术联合T-piece治疗新生儿呼吸窘迫综合征的临床观察[J].中国新生儿科杂志,2013,28(1):17-20. 被引量:11

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部